For Peter Mckie and Dr Anthony Lewis the answer was iPads, a yellow bag and some very clever software to simulate patient monitors and defibrillators.
Dr Anthony Lewis is the Chief Medical Officer at iSimulate. As an anaesthetist, he has been involved in medical education for over 20 years. As well as leading research and development at iSimulate, he continues to work as an anaesthetist at various hospitals in Sydney, Australia.
Peter Mckie is the Head of Strategy and Innovation at iSimulate. He worked as an intensive care paramedic before establishing Parasol EMT in Canberra, a healthcare training company with offices throughout Australia. He was the Chairman of the ACT Australian Resuscitation Council for 20 years and regularly teaches on Advanced Life Support courses.
Bobby Syed is the Chief Operating Officer for iSimulate. An entrepreneur at heart, he has become a leader and expert in sales, marketing, business development, exporting, and establishing new companies internationally. Bobby uses his vast knowledge in emergency services and corporate markets to focus on business growth and progressing iSimulate as a market leader.
In January 2020, 3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and the world’s leading manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, announced that it has entered into an agreement to acquire iSimulate Pty. Ltd. (“iSimulate”), a leader in clinical education technology offering smart and cost effective medical simulation solutions.“iSimulate has revolutionized simulation training in healthcare through its creative simulation solutions including ALSi, REALITi, CTGi and AURiS,” said Todd Murray, CEO of 3B Scientific. “We are extremely excited to further develop the 3BScientific platform and add the great products and people of iSimulate to our company. Our 3B Scientific global distribution footprint including fourteen commercial locations is uniquely positioned to further support and accelerate the growth of iSimulate products worldwide.”
iSimulate CEO Peter McKie added, “We are proud of the progress we have made with our company and Anthony, Bobby and I decided that the 3B Scientific team would be the best partner for us to expand and grow the business in the years to come. We are excited for the next step in our journey and appreciate the support from our customers worldwide. We look forward to working closely with Todd and his team.”
After the closing, Peter McKie, Anthony Lewis and Bobby Syed will remain active in the company and continue to drive the business plan for iSimulate. A significant emphasis for strong growth and the development of the product pipeline lies in the active collaboration from and partnership with the experts from 3B Scientific and Cardionics. iSimulate operations will remain unchanged and will continue to be based in both Canberra, Australia and Albany, NY.
The healthcare simulation market has experienced significant growth in the past decade and is estimated to reach USD $2.27 Billion by 2021, according to a 2016 MarketsandMarkets report.
The acquisition is anticipated to be consummated in the first quarter of 2020.Gibson, Dunn and Crutcher LLP and Clayton Utz are serving as legal advisors to 3B Scientific and J.H. Whitney Capital Partners, LLC. Schwartz Heslin Group, Inc. is acting as a financial advisor to iSimulate, and Pepper Hamilton LLP and MinterEllison are serving as legal advisors to iSimulate.